List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1191 studies with search of:   United States, Mississippi
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Completed Combination Chemotherapy in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride
22 Active, not recruiting Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclosporine
23 Recruiting Combination Chemotherapy in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
24 Active, not recruiting Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: paclitaxel
25 Completed Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: recombinant interferon alfa;   Drug: thalidomide
26 Active, not recruiting Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride
27 Completed Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer;   Gastric Cancer
Intervention: Drug: erlotinib hydrochloride
28 Active, not recruiting Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cephalexin;   Drug: ciprofloxacin;   Drug: trimethoprim-sulfamethoxazole;   Procedure: chemotherapy;   Procedure: surgical procedure
29 Active, not recruiting Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: aldesleukin;   Drug: cisplatin;   Drug: dacarbazine;   Drug: filgrastim;   Drug: recombinant interferon alfa;   Drug: vinblastine
30 Active, not recruiting Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: amifostine trihydrate;   Drug: carboplatin;   Drug: paclitaxel
31 Active, not recruiting Vinorelbine in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: vinorelbine ditartrate
32 Active, not recruiting Comparison of Cisplatin Combined With Either Paclitaxel or Gemcitabine in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel
33 Active, not recruiting Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
Conditions: Cancer-Related Problem/Condition;   Esophageal Cancer;   Gastric Cancer
Interventions: Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: triacetyluridine
34 Active, not recruiting Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa
Condition: Leukemia
Interventions: Drug: hydroxyurea;   Drug: omacetaxine mepesuccinate
35 Completed Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: irinotecan hydrochloride
36 Completed Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: irinotecan hydrochloride
37 Active, not recruiting Combination Chemotherapy Plus Filgrastim With or Without Thalidomide in Treating Patients With Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dexamethasone;   Drug: etoposide;   Drug: filgrastim;   Drug: thalidomide
38 Completed Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: FOLFIRI regimen;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium
39 Completed Combination Chemotherapy Plus Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: filgrastim;   Drug: paclitaxel;   Drug: topotecan hydrochloride
40 Recruiting Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: observation

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services